BNGO BIONANO GENOMICS INC

Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025

Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025

SAN DIEGO, March 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Monday, March 31, 2025, at 4:30 p.m. Eastern Time to report financial results for the fourth quarter and full year 2024 and to highlight recent corporate progress.

Conference Call & Webcast Details

Date:Monday, March 31st, 2025
Time:4:30 p.m. ET
Participant Link:
Webcast Link:

Participants may access a live webcast of the call on the Investors page of the Bionano website. A replay of the conference call and webcast will be archived on Bionano’s investor relations website at  for at least 30 days.

CONTACTS

Company Contact:

Erik Holmlin, CEO

Bionano Genomics, Inc.

+1 (858) 888-7610



EN
14/03/2025

Underlying

BNGOBIONANO GENOMICS INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on BIONANO GENOMICS INC

 PRESS RELEASE
Free
BNGO BIONANO GENOMIC...

Bionano Reports Second Quarter 2025 Results and Highlights Recent Busi...

Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress Conference call today, August 14, 2025, at 4:30 PM ET SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the second quarter ended June 30, 2025. “We continued to execute on our new strategy of focusing on our base of routine users of optical genome mapping (OGM) and VIA™ software as the primary drivers of our revenue and gross profit in the second quarter. These routine users are increasingly leveraging our OGM systems and software a...

6h / 57m 1 EN
 PRESS RELEASE
Free
BNGO BIONANO GENOMIC...

Bionano Announces Publication Showing Utility of Optical Genome Mappin...

Bionano Announces Publication Showing Utility of Optical Genome Mapping in Clinical Research of Infant & Toddler T-ALL SAN DIEGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a peer-reviewed publication from a team led by Manon Delafoy from the Institut Necker Enfants Malades (INEM) and colleagues from multiple French pediatric hematology centers showing how optical genome mapping (OGM) can be used to detect oncogenic structural variants (SVs) in clinical research of infant and toddler T-cell acute lymphoblastic leukemia (T-ALL). The publication...

August 7, 2025 1 EN
 PRESS RELEASE
Free
BNGO BIONANO GENOMIC...

Bionano to Present at the Canaccord Genuity 45th Annual Growth Confere...

Bionano to Present at the Canaccord Genuity 45th Annual Growth Conference SAN DIEGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the Canaccord Genuity 45th Annual Growth Conference on August 13, 2025. Conference & Webcast Details Date:August 13, 2025Time:3:00 p.m. to 3:25 p.m. ETPresenter:Erik Holmlin, PhD, CEO of BionanoWebcast: A replay / recording of the session will be available following the conference through the Bionano website at  for at...

August 6, 2025 1 EN
 PRESS RELEASE
Free
BNGO BIONANO GENOMIC...

Bionano Announces Upgrades to its Software and Compute Platforms to Ma...

Bionano Announces Upgrades to its Software and Compute Platforms to Make Analysis of OGM, Microarray and NGS Data Easier, Faster and More Accurate VIA™ 7.2 transforms the workflow for optical genome mapping (OGM) data analysis with AI in constitutional genetic disorders VIA 7.2 supercharges the OGM heme workflow by allowing AI to utilize a lab’s historical results to speed future interpretations VIA 7.2 extends significance associated with phenotype (SAP) scoring to OGM data for the first time and uses that score to help streamline interpretation decisions for OGM variantsVIA 7.2 includes s...

August 5, 2025 1 EN
 PRESS RELEASE
Free
BNGO BIONANO GENOMIC...

Bionano to Report Second Quarter 2025 Financial Results and Host a Con...

Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on August 14, 2025 SAN DIEGO, July 31, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Thursday, August 14, 2025, at 4:30 p.m. Eastern Time to report financial results for the second quarter 2025 and to highlight recent corporate progress. Conference Call & Webcast Details Date:Thursday, August 14th, 2025Time:4:30 p.m. ETParticipant Link:Webcast Link: Participants may access a live webcast of the call on the ...

July 31, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch